Brookfield Renews Talks for €7B Grifols Acquisition

Brookfield Asset Management Ltd. has renewed discussions with the Grifols family's main shareholders about potentially acquiring the Spanish blood-plasma company, Grifols SA, after a previous failed attempt. The proposed offer is valued at approximately €7 billion ($7.55 billion), as reported by El Confidencial. Following the news, Grifols' shares rose by about 9%, recovering from an 11% year-to-date decline on the IBEX 35 index. Brookfield's earlier €6.7 billion offer was rejected by Grifols management last November. Both Grifols and Brookfield have declined to comment on the current negotiations, which are ongoing and advised by Morgan Stanley. It remains uncertain if Brookfield will proceed with a formal offer.